Clinical Trials Early Career Investigators Showcase

CTAD is the only conference that brings together the world’s leading AD/ADRD clinical trialists working in academia, industry and not-for-profit organizations and has a focus on Alzheimer’s Disease therapeutic trials. CTAD is dedicated to promoting the professional development of these emerging leaders to ensure their success and career advancement

Early career investigators on a career track as an AD/ADRD therapeutic trials clinical investigator or principal investigator play a critical role in the advancement of AD/ADRD therapeutic research through new discoveries, improved methodologies, and translation of successful interventions into clinical care. These individuals will also design and lead the next generation of AD/ADRD clinical trials, build the global trials network and form the next generation of investigators and clinical trials leaders in the field.

Submission criteria for this category:

• Individuals can be from academia, industry, or not for profit organization
• Research projects must have direct relevance to AD/ADRD clinical trials design, conduct or analysis.
• Must be AD/ADRD clinical trials research  (only human trials) including but not limited to the areas of study design, biomarkers (imaging, biofluids, digital) outcomes, clinical/functional outcomes, recruitment and retention science, trials operations, statistical methodlogy and regulatory science.
• Individuals must be within 7 years of completing a terminal degree (e.g. MD, PhD, PharmD)

This category is for POSTER PRESENTATION only - A featured poster session at CTAD25 will highlight the top presentations from this category. 

Please note that if the Scientific Committee feels that your abstract is not a good fit for this category you will be redirected to another submission topic.